A Phase III Clinical Trial Assessing the Immunogenicity and Safety of Lyophilized Live-Attenuated Varicella Vaccine in Healthy Subjects Aged 13 to 55 Years
NCT06592456
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1200
Enrollment
OTHER
Sponsor class
Conditions
Chickenpox Vaccines
Interventions
BIOLOGICAL:
Chickenpox Vaccines
Sponsor
Southeast University, China